ARTICLE | Distillery Therapeutics
Cancer
July 25, 2017 8:44 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting SYNCRIP could help treat AML. In bone marrow samples from patients, SYNCRIP levels were higher than in hematopoietic stem and progenit...
BCIQ Company Profiles